On Thursday, February 25, 2021, Leavitt Partners held a LinkedIn Live broadcast focused on using budget reconciliation to advance health policy change in Congress, featuring Andrew Croshaw, Liz Wroe and Sara Singleton from Leavitt Partners. They discussed President Biden’s healthcare priorities as well as what healthcare organizations can do to impact health-related legislation. President Biden … Continue reading
Leavitt Partners is pleased to announce that Jeremy Bahr has joined the firm as a Principal. Jeremy will focus on developing solutions that cross between the intersection of value and strategy, within the life sciences sector. He helps build brands, deliver insights, and lead business transformations. Since 2018, Jeremy has worked as a consultant across … Continue reading
2020 was a year that no one could have predicted with the onset of the pandemic and its impact to the U.S. economy. As we head into 2021, the end of pandemic is in sight. However, we continue to see pervasive daily increases in coronavirus cases, high death rates, and continued challenges around the rollout … Continue reading
Today, Leavitt Partners released “Addressing Health Disparities Among Racially & Culturally Diverse Populations in Utah During COVID-19,” a final report discussing the spotlight COVID-19 has put on health disparities in Utah and around the nation. The report was conducted in partnership with the Multicultural Advisory Committee of Utah’s COVID-19 Response and analyzes the national landscape … Continue reading
While we are still examining the 2020 election results and how voters’ personal experiences with the pandemic and financial upheaval influenced their decisions, Governor Leavitt made eight important observations about the election that will shape the ensuing healthcare policy environment. He recently discussed the following observations during Leavitt Partners’ biannual Political Checkpoint webinar. Observation #1: It … Continue reading
Cell and gene therapies (CGTs) are some of the most promising and exciting medical advancements taking place today. Some existing CGTs treat previously untreatable rare diseases, and there are hundreds of CGTs in clinical development to treat various types of cancer, hemophilia, sickle cell and other blood disorders, Alzheimer’s disease, and numerous rare conditions. The … Continue reading
Today, Leavitt Partners announced the acquisition of Torch Insight® by Milliman, Inc. This acquisition will combine Torch Insight’s powerful market-centered data and analytics with MedInsight, Milliman’s flagship healthcare analytics ecosystem. Torch Insight brings Milliman decades of healthcare policy expertise and healthcare analytic experience backed by Leavitt Partners – recognized experts in the health sector. The … Continue reading
On June 23, 2020, Governor Michael O. Leavitt, former United States Secretary of Health and Human Services testified before the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) in a hearing titled, “COVID-19: Lessons Learned to Prepare for the Next Pandemic.” HELP Committee Chairman Lamar Alexander (R-TN) released a white paper titled “Preparing … Continue reading
Tomorrow, Governor Michael O. Leavitt, former U.S. Secretary for Health and Human Services (HHS), will testify before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP). The hearing is titled “COVID-19: Lessons Learned to Prepare for the Next Pandemic.” Governor Leavitt will share insights from his time as HHS Secretary, where he worked … Continue reading
Today, Leavitt Partners released “COVID-19 Hotspots,” a white paper that informs policymakers, industry leaders, and other key stakeholders to quickly assess where to deploy resources during the ongoing pandemic, and the accompanying, free tool that provides a daily updated map of where COVID-19 hotspots are forming in the United States. The authors discuss the nuances … Continue reading
